Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
ADMA Biologics Inc (ADMA) had Normalized Pre-Tax Income of $33.45M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$114.80M |
|
$26.90M |
|
$53.70M |
|
$61.10M |
|
$79.92M |
|
$34.88M |
|
$-1.43M |
|
$33.45M |
|
|
Normalized Pre-Tax Income |
$33.45M |
$26.90M |
|
$26.90M |
|
$26.90M |
|
$26.90M |
|
$34.88M |
|
$37.00M |
|
237.78M |
|
244.68M |
|
$0.11 |
|
$0.11 |
|
| Balance Sheet Financials | |
$351.81M |
|
$57.71M |
|
$158.75M |
|
$510.57M |
|
$53.50M |
|
$80.83M |
|
$83.65M |
|
$137.15M |
|
$373.42M |
|
$369.44M |
|
$373.42M |
|
238.53M |
|
| Cash Flow Statement Financials | |
$-19.68M |
|
$-4.72M |
|
$-7.13M |
|
$103.15M |
|
$71.62M |
|
$-31.52M |
|
$4.62M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.58 |
|
-- |
|
-- |
|
0.18 |
|
0.22 |
|
53.22% |
|
30.38% |
|
30.38% |
|
-- |
|
29.14% |
|
23.44% |
|
$-24.38M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
0.31 |
|
1.15 |
|
77.93 |
|
7.20% |
|
7.28% |
|
5.27% |
|
5.92% |
|
$1.57 |
|
$-0.10 |
|
$-0.08 |
|